Dr. Deowall Chattar-Cora, MD

Dr. Chattar-Cora practices at Elite Plastic & Reconstructive Surgery in San Antonio, Texas.

Dr. Chattar-Cora's NPI, 1699733576, was assigned on May 2, 2006. Dr. Chattar-Cora graduated from New York University School of Medicine in 1996. Dr. Chattar-Cora holds Texas license M3496.

Dr. Chattar-Cora's primary practice is Elite Plastic & Reconstructive Surgery, at 11212 State Highway 151, San Antonio, TX 78251-4498. The practice phone is (210) 265-1924.

Dr. Chattar-Cora's primary practice is Elite Plastic & Reconstructive Surgery in San Antonio, Texas. Dr. Chattar-Cora is also affiliated with CHRISTUS Santa Rosa Hospital - Westover Hills.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chattar-Cora practices, 2 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Chattar-Cora's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Chattar-Cora is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Chattar-Cora's licenses on file in 3 states: Texas, Florida and New York.

Dmand AI lists cancerous skin growth removal and removal of damaged skin or skin graft among the conditions Dr. Chattar-Cora treats.

CMS data shows 349 Medicare services from Dr. Chattar-Cora across 6 procedure codes in 2024, for 79 Medicare patients. Medicare paid $45,372 for them.

CMS counts 79 Medicare patients who saw Dr. Chattar-Cora in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chattar-Cora's median patient age at 58, with 53% women.

In 2024, Dr. Chattar-Cora wrote 59 Medicare Part D claims for 24 patients. 98% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $260 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Chattar-Cora accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of removal of tissue by Dr. Chattar-Cora, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Chattar-Cora in 2002. 2002 was the busiest year, with 2. The most frequent topics are Hispanic or Latino, Surgical Flaps and Colorectal Neoplasms. Dr. Chattar-Cora has published most often in Ann Plast Surg. Dr. Chattar-Cora's most frequent co-authors are Richard Delaney, MD, Markian Kunasz, MD and Rocco R. Tutela, MD.

CMS Open Payments shows 18 general payments to Dr. Chattar-Cora from 8 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 40% of the total. Integra LifeSciences Corporation paid the most, $1,759.

Dr. Chattar-Cora graduated from New York University School of Medicine in 1996. Dr. Chattar-Cora is a member of ASPS.

Dr. Chattar-Cora is in network with 11 carriers, including Aetna, United Healthcare and Humana. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.